Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA442938
Max Phase: Preclinical
Molecular Formula: C39H54O6
Molecular Weight: 618.86
Molecule Type: Small molecule
Associated Items:
ID: ALA442938
Max Phase: Preclinical
Molecular Formula: C39H54O6
Molecular Weight: 618.86
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(COC(=O)/C=C/c4ccc(O)cc4)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12
Standard InChI: InChI=1S/C39H54O6/c1-24-15-20-38(34(43)44)21-22-39(23-45-32(42)14-9-26-7-10-27(40)11-8-26)28(33(38)25(24)2)12-13-30-36(5)18-17-31(41)35(3,4)29(36)16-19-37(30,39)6/h7-12,14,24-25,29-31,33,40-41H,13,15-23H2,1-6H3,(H,43,44)/b14-9+/t24-,25+,29+,30-,31+,33+,36+,37-,38+,39+/m1/s1
Standard InChI Key: RZHJGXXCTIXCRI-HLWIYMQRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 618.86 | Molecular Weight (Monoisotopic): 618.3920 | AlogP: 8.03 | #Rotatable Bonds: 5 |
Polar Surface Area: 104.06 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.49 | CX Basic pKa: | CX LogP: 8.03 | CX LogD: 5.21 |
Aromatic Rings: 1 | Heavy Atoms: 45 | QED Weighted: 0.18 | Np Likeness Score: 2.64 |
1. Nishimura K, Fukuda T, Miyase T, Noguchi H, Chen XM.. (1999) Activity-guided isolation of triterpenoid acyl CoA cholesteryl acyl transferase (ACAT) inhibitors from Ilex kudincha., 62 (7): [PMID:10425145] [10.1021/np990019j] |
2. Wang C, Wang R, Chen Y, Wang L, Zhou S, Wang H.. (2019) Discovery of an EGFR tyrosine kinase inhibitor from Ilex latifolia in breast cancer therapy., 29 (11): [PMID:30962086] [10.1016/j.bmcl.2019.04.009] |
3. Kruakaew S, Seeka C, Yahuafai J, Siripong P, Sutthivaiyakit S.. (2019) Cytotoxic 20,22-Dihydrodigitoxigenin Glycosides and Other Constituents of Vallaris glabra Stems., 82 (12): [PMID:31820973] [10.1021/acs.jnatprod.9b00803] |
Source(1):